Insmed Inc’s recently made public that its Officer Lewis William acquired Company’s shares for reported $1.99 million on Feb 03 ’25. In the deal valued at $77.91 per share,25,580 shares were bought.
Then, Schaeffer Orlov S Nicole sold 91,140 shares, generating $7,291,200 in total proceeds. Upon selling the shares at $80.00, the Chief People Strategy Officer now owns 97,083 shares.
Before that, Schaeffer Orlov S Nicole bought 91,140 shares. Insmed Inc shares valued at $7,291,200 were divested by the Officer at a price of $80.00 per share.
Truist initiated its Insmed Inc [INSM] rating to a Buy in a research note published on April 23, 2024; the price target was $48. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”an Outperform”‘ rating. Wells Fargo began covering INSM with “an Overweight” recommendation on December 08, 2023.
Price Performance Review of INSM
On Monday, Insmed Inc [NASDAQ:INSM] saw its stock jump 1.70% to $77.88. Over the last five days, the stock has gained 0.32%. Insmed Inc shares have risen nearly 12.80% since the year began. Nevertheless, the stocks have risen 180.14% over the past one year. While a 52-week high of $80.63 was reached on 01/30/25, a 52-week low of $21.92 was recorded on 01/10/25. SMA at 50 days reached $72.75, while 200 days put it at $64.90.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 75.29, which if violated will result in even more drops to 72.69. On the upside, there is a resistance level at 79.66. A further resistance level may holdings at 81.43. The Relative Strength Index (RSI) on the 14-day chart is 62.43, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.19, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 20.79%. Stochastics %K at 77.52% indicates the stock is a holding.
How much short interest is there in Insmed Inc?
A steep rise in short interest was recorded in Insmed Inc stocks on 2025-01-15, growing by 2.08 million shares to a total of 15.09 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 13.01 million shares. There was a rise of 13.78%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 26, 2023 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $50 price target.
